United States
Three decades of Global Medical Device, Diagnostics, Biotechnology, and Pharmaceutical Sales, Marketing, Business Development, Strategy, Leading People, NPD, and General Management experience with Fortune 50 to 500 companies, med tech start-ups, and incubator projects. Proven track record in US Biotech, Pharmaceutical and Medical Device Industry, Latin America Medical Devices and Pharmaceuticals, US Diagnostics, APAC Medical Devices, and EMEA Medical Devices and Pharma/Medical Supplies. Robust experience in B2B strategy and business development in clinical, consumer, hospital, ASC and research markets. Have been directly accountable for P&L operations/businesses in several countries/regions/continents ranging from $25M to ~$9 Billion+ Have lived, studied, and worked in three continents. Multilingual and multifunctional employee with high versatility and proven leadership abilities. Experience encompasses direct in-region assignments in the US, LATIN AMERICA, EMEA, and APAC. Specialties: General Management, Turn-arounds, Strategic Planning, New Business Development, Global Marketing, Sales, Sales Management, Start-up operations, product Launching, coaching, leadership development, Medical Devices/Pharmaceutical operations, and P&L Responsibilities globally Publicly traded company board membership. Experienced in IPOs and complex financial restructuring.
President, CEO and Chairman of Zimmer Biomet. A Fortune 500 company which, for the last century, has been obsessed with alleviating pain and improving the quality of life for people around the world. Entering a new chapter of transformation at Zimmer Biomet solving now the most meaningful problems in healthcare. Passionate about people and purpose.
Honored to lead an amazing organization full of committed team members who wake up every day ready to positively disrupt the delivery of healthcare for millions of patients. Zimmer Biomet is a mission-centric, Fortune 500 company transforming musculoskeletal care one patient at a time. We operate in over 125 countries and lead the way in alleviating pain and improving the quality of life for people around the world. NYSE: ZBH
Accountability for all businesses/operations globally for Zimmer Biomet. A FORTUNE 500 company with $8.6B in revenue ($33 billion market cap), ~30% operating income, and ~$1.8 billion operating cash flow changing the world LITERALLY one patient at a time. We serve north of 3.5 million lives per year and do so with relentless passion. Leading a strategic, operational, and cultural turn-around